{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:06:27Z","timestamp":1777496787613,"version":"3.51.4"},"reference-count":35,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CH"],"published-print":{"date-parts":[[2021,5,6]]},"abstract":"<jats:p>OBJECTIVE: The aim of the present study was to evaluate the effectiveness and safety of nicorandil in improving the area of myocardial infarction in patients with acute myocardial infarction (AMI). METHODS: One hundred and twenty patients with acute ST-segment elevation myocardial infarction (STEMI) admitted to our hospital between December 1, 2018 and December 31, 2019 were selected and randomly allocated to the experimental group (group A, n\u200a=\u200a60) and the control group (group B, n\u200a=\u200a60). In the experimental group, an infusion of nicorandil was given intravenously before the first balloon dilation or 1 minute before the stent placement, and with the completion of the infusion, nicorandil maintenance infusion was given. In the control group, only balloon dilation and stent placement were undertaken. RESULTS: The postoperative peak levels of myoglobin, creatine kinase isoform and hypersensitive troponin T were significantly lower in group A than in group B (p\u200a&lt;\u200a0.05). Moreover, the left ventricular ejection fraction (LVEF) on the 180th day post operation was substantially greater in group A than in group B (p\u200a&lt;\u200a0.01), and the area of myocardial infarction was significantly smaller in patients in group A than those in group B on the 180th day post operation (p\u200a&lt;\u200a0.01). In terms of the safety, there were no statistically significant differences in the incidence of slow flow\/no reflow, malignant arrhythmias, and hypotension within 24 hours post operation between the two groups (p\u200a&gt;\u200a0.05), and no major adverse cardiovascular event (MACE) occurred in either group during the postoperative follow-up period of 180 days (p\u200a&gt;\u200a0.05). CONCLUSION: Intravenous administration of nicorandil in patients with STEMI during the perioperative percutaneous coronary intervention (PCI) period was effective in reducing the area of myocardial infarction and myocardial injury without increasing the incidence of malignant arrhythmias, hypotension, or composite cardiovascular events during the drug administration period.<\/jats:p>","DOI":"10.3233\/ch-200998","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T10:59:41Z","timestamp":1609239581000},"page":"411-423","source":"Crossref","is-referenced-by-count":15,"title":["Effect of intravenous application of nicorandil on area of myocardial infarction in patients with STEMI during the perioperative stage of PCI"],"prefix":"10.1177","volume":"77","author":[{"given":"Zheng-Dong","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Yulin First People\u2019s Hospital, The Sixth Affiliated Hospital of Guangxi Medical University, Yulin, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yulin First People\u2019s Hospital, The Sixth Affiliated Hospital of Guangxi Medical University, Yulin, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yulin First People\u2019s Hospital, The Sixth Affiliated Hospital of Guangxi Medical University, Yulin, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yulin First People\u2019s Hospital, The Sixth Affiliated Hospital of Guangxi Medical University, Yulin, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yulin First People\u2019s Hospital, The Sixth Affiliated Hospital of Guangxi Medical University, Yulin, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Wen","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yulin First People\u2019s Hospital, The Sixth Affiliated Hospital of Guangxi Medical University, Yulin, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Zhang","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yulin First People\u2019s Hospital, The Sixth Affiliated Hospital of Guangxi Medical University, Yulin, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yulin First People\u2019s Hospital, The Sixth Affiliated Hospital of Guangxi Medical University, Yulin, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"03","key":"10.3233\/CH-200998_ref1","first-page":"209","article-title":"Summary of the 2018 Report on Cardiovascular Diseases in China","volume":"34","author":"Hu Shengshou","year":"2019","journal-title":"Chinese Circulation Journal"},{"issue":"12","key":"10.3233\/CH-200998_ref2","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.5603\/KP.2018.0228","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"76","author":"Neumann","year":"2018","journal-title":"Kardiologia Polska"},{"issue":"z1","key":"10.3233\/CH-200998_ref3","first-page":"6","article-title":"2018 ESC\/EACTS Guidelines for Myocardial Reconstruction Explained","volume":"33","author":"Wu Si Jing","year":"2018","journal-title":"Chinese Circulation Journal"},{"key":"10.3233\/CH-200998_ref4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0735-1097(93)90700-B","article-title":"Does reperfusion injury exist in humans","volume":"21","author":"RA K","year":"1993","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.3233\/CH-200998_ref5","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.hlc.2018.05.097","article-title":"Effects of Early Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction","volume":"28","author":"Feng","year":"2019","journal-title":"Heart, Lung and Circulation"},{"issue":"5","key":"10.3233\/CH-200998_ref6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0735-1097(97)00277-5","article-title":"Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction","volume":"30","author":"Taniyama","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.3233\/CH-200998_ref7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0002-8703(97)70162-5","article-title":"Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction","volume":"133","author":"Sakata","year":"1997","journal-title":"Am Heart J"},{"key":"10.3233\/CH-200998_ref8","doi-asserted-by":"crossref","unstructured":"Wang Q , Shen H , Mao H , et al. Shock Index on Admission Is Associated with Coronary Slow\/No Reflow in Patients with Acute Myocardial Infarction Undergoing Emergent Percutaneous Coronary Intervention. 2019,20(03):1450\u20131460.","DOI":"10.1155\/2019\/7873468"},{"issue":"2","key":"10.3233\/CH-200998_ref9","first-page":"278","article-title":"Myocardial no-reflow treatment","volume":"11","author":"Muller","year":"2013","journal-title":"Current Vascular Pharmacology"},{"issue":"9819","key":"10.3233\/CH-200998_ref10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(11)61872-2","article-title":"Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomized trial","volume":"379","author":"Thiele","year":"2012","journal-title":"Lancet (London, England)."},{"key":"10.3233\/CH-200998_ref11","doi-asserted-by":"crossref","unstructured":"Kumar J , O\u2019Connor CT . Coronary no-reflow in the modern era: a review of advances in diagnostic techniques and contemporary management. 2019;17(8):605\u2013623.","DOI":"10.1080\/14779072.2019.1653187"},{"issue":"21","key":"10.3233\/CH-200998_ref12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0002-9149(89)90200-2","article-title":"Nicorandil as a hybrid between nitrates and potassium channel activators","volume":"63","author":"Taira","year":"1989","journal-title":"The American Journal of Cardiology"},{"issue":"24","key":"10.3233\/CH-200998_ref13","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1161\/01.CIR.97.24.2463","article-title":"Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection?","volume":"97","author":"Liu","year":"1998","journal-title":"Circulation"},{"issue":"04","key":"10.3233\/CH-200998_ref14","first-page":"520","article-title":"Intracoronary administration of nicorandil-induced cardiac arrest during primary percutaneous coronary intervention","volume":"15","author":"Wei","year":"2019","journal-title":"Medicine"},{"issue":"04","key":"10.3233\/CH-200998_ref15","first-page":"560","article-title":"Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention","volume":"12","author":"Zhao","year":"2019","journal-title":"BMC Cardiovascular Disorders"},{"issue":"3","key":"10.3233\/CH-200998_ref16","first-page":"11","article-title":"2012 Global Definition of Myocardial Infarction Explained","volume":"3","author":"Ma Yuliang","year":"2015","journal-title":"Chinese Journal of Cardiovascular Disease"},{"issue":"3","key":"10.3233\/CH-200998_ref17","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3892\/etm.2015.2623","article-title":"Intracoronary administration of anisodamine and nicorandil in individuals undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction: A randomized factorial trial","volume":"10","author":"Chen","year":"2015","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"7","key":"10.3233\/CH-200998_ref18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/0003319715605977","article-title":"Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention","volume":"67","author":"Celik","year":"2016","journal-title":"Angiology"},{"issue":"1","key":"10.3233\/CH-200998_ref19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.carrev.2012.10.006","article-title":"The prognosis of periprocedural myocardial infarction after percutaneous coronary interventions","volume":"14","author":"Zimarino","year":"2013","journal-title":"Cardiovascular Revascularization Medicine: Including Molecular Interventions"},{"issue":"2","key":"10.3233\/CH-200998_ref20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/heart.87.2.162","article-title":"The \u201cno-reflow\u201d phenomenon: basic science and clinical correlates","volume":"87","author":"Reffelmann","year":"2002","journal-title":"Heart"},{"key":"10.3233\/CH-200998_ref21","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.biopha.2018.07.014","article-title":"Role of TLR4\/MyD88\/NF-kappaB signaling pathway in coronary microembolization-induced myocardial injury prevented and treated with nicorandil","volume":"106","author":"Su","year":"2018","journal-title":"Biomedicine & Pharmacotherapy=Biomedecine & Pharmacotherapie"},{"issue":"9","key":"10.3233\/CH-200998_ref22","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1586\/14779072.2015.1070669","article-title":"Myocardial protection from ischemia-reperfusion injury post coronary revascularization","volume":"13","author":"Binder","year":"2015","journal-title":"Expert Review of Cardiovascular Therapy"},{"issue":"12","key":"10.3233\/CH-200998_ref23","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00259-007-0423-4","article-title":"Nitrate-enhanced gated SPECT in patients with primary angioplasty for acute myocardial infarction: evidence of a reversible and nitrate-sensitive impairment of myocardial perfusion","volume":"34","author":"Djaballah","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/CH-200998_ref24","first-page":"278","article-title":"Myocardial no-reflow treatment","volume":"11","author":"Olivier","year":"2013","journal-title":"Curr Vasc Pharmacology"},{"issue":"9","key":"10.3233\/CH-200998_ref25","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s00380-015-0752-3","article-title":"Impacts of nicorandil on infarct myocardium in comparison with nitrate: assessed by cardiac magnetic resonance imaging","volume":"31","author":"Yamada","year":"2015","journal-title":"Heart and Vessels"},{"key":"10.3233\/CH-200998_ref26","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.12659\/MSM.906815","article-title":"Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction","volume":"24","author":"Qi","year":"2018","journal-title":"Medical Science Monitor: International Medical Journal of Experimental and Clinical Research"},{"issue":"1","key":"10.3233\/CH-200998_ref27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.15420\/ecr.2018.9.2","article-title":"Nicorandil and Long-acting Nitrates: Vasodilator Therapies for the Management of Chronic Stable Angina Pectoris","volume":"13","author":"Tarkin","year":"2018","journal-title":"European Cardiology"},{"key":"10.3233\/CH-200998_ref28","doi-asserted-by":"crossref","unstructured":"Li Y , Liu H , Peng W , et al. Nicorandil improves clinical outcomes in patients with stable angina pectoris requiring PCI: a systematic review and meta-analysis of 14 randomized trials. 2018;11(9):855\u2013865.","DOI":"10.1080\/17512433.2018.1508342"},{"issue":"8","key":"10.3233\/CH-200998_ref29","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.19082\/4934","article-title":"Effect of nicorandil on QT dispersion in patients with stable angina pectoris undergoing elective angioplasty: A triple-blind, randomized, placebo-controlled study","volume":"9","author":"Suleimani","year":"2017","journal-title":"Electronic Physician"},{"issue":"1","key":"10.3233\/CH-200998_ref30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11845-019-02034-3","article-title":"The effect of nicorandil in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a systematic review and meta-analysis","volume":"189","author":"Ji","year":"2020","journal-title":"Irish Journal of Medical Science"},{"issue":"1","key":"10.3233\/CH-200998_ref31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bbrc.2017.11.041","article-title":"Nicorandil alleviates myocardial injury and post-infarction cardiac remodeling by inhibiting Mst1","volume":"495","author":"Wang","year":"2018","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"3","key":"10.3233\/CH-200998_ref32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5847\/wjem.j.1920-8642.2020.03.005","article-title":"Effects of intracoronary injection of nicorandil and tirofiban on myocardial perfusion and short-term prognosis in elderly patients with acute ST-segment elevation myocardial infarction after emergency PCI","volume":"11","author":"Chen","year":"2020","journal-title":"World Journal of Emergency Medicine"},{"issue":"3","key":"10.3233\/CH-200998_ref33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9149(99)00736-5","article-title":"ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators","volume":"85","author":"de Lemos","year":"2000","journal-title":"The American Journal of Cardiology"},{"issue":"6","key":"10.3233\/CH-200998_ref34","first-page":"541","article-title":"Normalisation of elevated ST segment predicts return of left ventricular systolic function and improved outcome in patients with acute myocardial infarction, treated with primary coronary angioplasty","volume":"60","author":"Tomaszuk-Kazberuk","year":"2004","journal-title":"Kardiologia Polska"},{"issue":"2","key":"10.3233\/CH-200998_ref35","first-page":"211","article-title":"Intracoronary nicorandil prior to reperfusion in acute myocardial infarction","volume":"2","author":"Miyazawa","year":"2006","journal-title":"EuroIntervention: Journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology"}],"container-title":["Clinical Hemorheology and Microcirculation"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CH-200998","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:04:52Z","timestamp":1777388692000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CH-200998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":35,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/ch-200998","relation":{},"ISSN":["1386-0291","1875-8622"],"issn-type":[{"value":"1386-0291","type":"print"},{"value":"1875-8622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,6]]}}}